PMA device
AtriCure Synergy Ablation System
AtriCure, Inc. · Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation (OCM, Class III) · First FDA decision Dec 14, 2011, newest Nov 15, 2022Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
6
Naming "AtriCure Synergy"
MAUDE reports
28
Brand "AtriCure Synergy", since 2015
PubMed studies
0
Mentioning "AtriCure Synergy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AtriCure Synergy Ablation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- AtriCure Synergy Ablation SystemPMA supplement
P100046-S013 · Decided Nov 15, 2022 · 259 days after receipt · Normal 180 Day Track
Device type: Surgical cardiac ablation device, for treatment of atrial fibrillation (OCM) · Cardiology
- AtriCure Synergy Ablation SystemPMA supplement
P100046-S011 · Decided Nov 20, 2020 · 507 days after receipt · Normal 180 Day Track
Device type: Surgical cardiac ablation device, for treatment of atrial fibrillation (OCM) · Cardiology
- AtriCure Synergy Ablation SystemPMA supplement
P100046-S010 · Decided Jun 26, 2019 · 180 days after receipt · Normal 180 Day Track No User Fee
Device type: Surgical cardiac ablation device, for treatment of atrial fibrillation (OCM) · Cardiology
3 more FDA decisions with a free account
Older decisions: P100046-S003, P100046-S001, P100046
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Surgical Treatment of NailsProposed local determinationProposedDL40462Noridian Healthcare Solutions, LLCUpdated Sep 23, 2026
- Surgical Treatment of Obstructive Sleep Apnea (OSA)Local determinationIn effectL34526WPS Insurance CorporationUpdated Jun 16, 2025
- Surgical Treatment of NailsLocal determinationIn effectL33833First Coast Service Options, Inc.Updated Mar 14, 2025
- Surgical Treatment of NailsLocal determinationIn effectL34887Novitas Solutions, Inc.Updated Mar 14, 2025
- Surgical Treatment of NailsLocal determinationIn effectL39258Palmetto GBAUpdated Mar 3, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "AtriCure Synergy", any status and sponsor, newest update first.
- HEAL-IST IDE TrialActive, not recruiting
AtriCure, Inc.Public (ATRC)
NCT05280093 · 100 participants · Start May 31, 2022 · Primary completion Feb 2027
Device: AtriCure ISOLATOR Synergy Surgical Ablation System · For: Inappropriate Sinus Tachycardia
Sites: Jonesboro, Arkansas; Loma Linda, California; Redwood City, California · 27 sites in all
University Hospital, ToulouseAcademic, hospital or other
NCT02630914 · 12 participants · Start Sep 2015 · Primary completion Mar 2018
Device: The AtriCure Synergy Ablation System · For: Atrial Fibrillation (AF)
Sites: Toulouse, France
- Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation to Prevent Atrial Fibrillation After Cardiac SurgeryPivotal-lookingRecruiting
Vasily I. KaledaAcademic, hospital or other
NCT06823778 · 216 participants (planned) · Start Feb 17, 2025 · Primary completion Sep 2027
Device: Radiofrequency ablation · For: Postoperative Atrial Fibrillation
Sites: Moscow, Russia
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AtriCure Synergy", and for the whole product code for context.
This brand
28 reports: 0 malfunction, 27 injury, 1 death
Whole product code OCM
70 reports: 10 malfunction, 53 injury, 7 death
Newest reports for this brand
3011706110-2023-00021 · Received May 26, 2023
Device type: Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation (OCM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pulmonary Valve Stenosis; Stenosis
3011706110-2022-00039 · Received Nov 9, 2022
Device type: Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation (OCM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pulmonary Valve Stenosis
3011706110-2022-00022 · Received Jul 7, 2022 · Event dated Jun 6, 2022
Device type: Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation (OCM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Great Vessel Perforation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AtriCure Synergy"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OCM.
- EPi-Sense Guided Coagulation SystemAtriCure, Inc. · PMA 2025
- Synergy Ablation SystemAtriCure, Inc. · PMA 2025
- Cannula with GuideAtriCure, Inc. · PMA 2024
- EPi-Sense®, EPi-Sense ST Guided Coagulation SystemAtriCure, Inc. · PMA 2022
- EPi-Sense® ST Guided Coagulation SystemAtriCure, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.